Pancreatic Cell News Volume 14.37 | Sep 26 2023

    0
    15








    2023-09-26 | PACN 14.37


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 14.37 – 26 September, 2023
    TOP STORY

    BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma

    By small molecule compound screening targeting 142 epigenetic enzymes, researchers identified that bromodomain-containing protein BRD9 was a key chromatin regulator to orchestrate the stemness of pancreatic cancer stem cells.
    [Gastroenterology]

    AbstractFull Article
    PUBLICATIONSRanked by the impact factor of the journal

    A Wireless, Battery-Free Device Enables Oxygen Generation and Immune Protection of Therapeutic Xenotransplants In Vivo

    The device showed the potential to enable subcutaneous survival of encapsulated islet cells, in vivo in awake, freely moving, immune-competent animals.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    AbstractPress Release

    Decellularized Human Pancreatic Extracellular Matrix-Based Physiomimetic Microenvironment for Human Islet Culture

    Researchers demonstrated that incorporating human pancreatic decellularized extracellular matrix within alginate microcapsules resulted in a significant increase in Glucose Stimulation Index and total insulin secreted by encapsulated human islets, compared to free islets and islets encapsulated in only alginate.
    [Acta Biomaterialia]

    Full ArticleGraphical Abstract

    Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes Assessed by Retrospective Continuous Glucose Monitoring

    In this randomized and placebo-controlled trial, a total of 73 patients were randomly assigned to receive intravenous infusion of umbilical cord-derived mesenchymal stem cells or placebo, three times at four-week intervals and followed up for 48 weeks.
    [Stem Cells Translational Medicine]

    Full ArticleGraphical Abstract

    Scalable Generation of 3D Pancreatic Islet Organoids from Human Pluripotent Stem Cells in Suspension Bioreactors

    Scientists describe scalable techniques for generating 10,000–100,000 organoids that further mature in 4–5 weeks into α- and β-like cells with glucose-responsive insulin and glucagon release.
    [Star Protocols]

    Full ArticleGraphical Abstract

    Fructose-Induced mTORC1 Activation Promotes Pancreatic Cancer Progression through Inhibition of Autophagy

    Fructose could be taken up and metabolized by PDAC cells and provided an adaptive survival mechanism for PDAC cells under glucose deficient conditions.
    [Cancer Research]

    Abstract

    FABP4 in Macrophages Facilitates Obesity-Associated Pancreatic Cancer Progression via the NLRP3/IL-1β Axis

    In vivo and in vitro experiments revealed that fatty acid-binding protein 4 (FABP4) induced macrophage-related inflammation to promote pancreatic cancer cell migration, invasion, and metastasis under obese condition.
    [Cancer Letters]

    Abstract

    Post-Translational Modification of CDK1–STAT3 Signaling by Fisetin Suppresses Pancreatic Cancer Stem Cell Properties

    Scientists demonstrated that CDK1 was correlated with prognosis and was highly expressed in pancreatic cancer tissue and gemcitabine-resistant cells
    [Cell & Bioscience]

    Full Article

    SLC35F2–SYVN1–TRIM59 Axis Critically Regulates Ferroptosis of Pancreatic Cancer Cells by Inhibiting Endogenous p53

    Through multi-omics analyses, investigators discerned that solute carrier family 35 member F2 (SLC35F2) influenced the transcriptome and inhibited ferroptosis in pancreatic cancer cells.
    [Oncogene]

    Abstract
    Request your free copy of the 'Growing Organoids from Stem Cells' Wallchart
    REVIEWS

    The Beta Cell-Immune Cell Interface in Type 1 Diabetes (T1D)

    The authors discuss current state of the art and consider knowledge gaps concerning the interface of the islet beta cell with immune infiltrates, with a focus on T cells.
    [Molecular Metabolism]

    Full Article

    Metabolic Regulation of Glucagon Secretion

    Scientists describe how various nutrients are sensed, transported and metabolised in alpha cells, providing an integrative model for the metabolic regulation of glucagon secretion and action.
    [Journal Of Endocrinology]

    Full Article
    INDUSTRY AND POLICY NEWS

    The Pancreatic Cancer Action Network Selects Oncolytics Biotech® Inc. to Receive $5 Million Therapeutic Accelerator Award to Develop Leading-Edge Treatments

    The $5 million grant will enable Oncolytics to continue the next stage of its research focused on a clinical trial with Oncolytics’ proprietary reovirus pelareorep in combination with modified FOLFIRINOX chemotherapy, with or without an immune checkpoint inhibitor.
    [Oncolytics Biotech Inc.]

    Press Release
    FEATURED EVENT

    The Tumor Landscape: Translating Mechanism to Therapy

    October 29 – November 1, 2023
    New York, New York, United States

    > See All Events

    JOB OPPORTUNITIES

    Associate Professor – Physiology

    The University of Tennessee – Memphis, Tennessee, United States

    Faculty Position – Endocrinology, Diabetes & Metabolism

    Beth Israel Deaconess Medical Center & Harvard Medical School – Boston, Massachusetts, United States

    Assistant Professor – Cancer, Cardiovascular and Metabolic Health, or Brain, Mind, and Behavior

    Northwestern University – Chicago, Illinois, United States

    Faculty Positions – Cancer Metastasis

    The Sidney Kimmel Cancer Center – Philadelphia, Pennsylvania, United States

    Post Doctoral Fellow – Autoimmunity and Transplantation

    University of Missouri – Columbia, Missouri, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter